Health Catalyst, Inc.
NASDAQ:HCAT
7.68 (USD) • At close November 4, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Revenue
| 295.938 | 276.236 | 241.926 | 188.845 | 154.941 | 112.574 | 73.081 |
| Cost of Revenue
| 203.336 | 143.049 | 124.354 | 98.077 | 75.345 | 59.852 | 43.642 |
| Gross Profit
| 92.602 | 133.187 | 117.572 | 90.768 | 79.596 | 52.722 | 29.439 |
| Gross Profit Ratio
| 0.313 | 0.482 | 0.486 | 0.481 | 0.514 | 0.468 | 0.403 |
| Reseach & Development Expenses
| 68.503 | 75.68 | 62.733 | 53.517 | 46.252 | 38.592 | 28.47 |
| General & Administrative Expenses
| 76.559 | 61.701 | 85.934 | 59.24 | 31.713 | 22.69 | 14.697 |
| Selling & Marketing Expenses
| 67.321 | 87.514 | 75.027 | 55.411 | 47.284 | 44.123 | 25.92 |
| SG&A
| 109.857 | 149.215 | 160.961 | 114.651 | 78.997 | 66.813 | 40.617 |
| Other Expenses
| 0.004 | 48.297 | 37.528 | 18.725 | 9.212 | -0.039 | -0.004 |
| Operating Expenses
| 178.36 | 273.192 | 261.222 | 186.893 | 134.461 | 112.817 | 74.979 |
| Operating Income
| -85.758 | -140.005 | -143.65 | -96.125 | -54.865 | -60.095 | -45.54 |
| Operating Income Ratio
| -0.29 | -0.507 | -0.594 | -0.509 | -0.354 | -0.534 | -0.623 |
| Total Other Income Expenses Net
| -32.033 | -1.678 | -16.458 | -20.086 | -5.089 | -0.039 | -0.004 |
| Income Before Tax
| -117.791 | -141.683 | -160.108 | -116.211 | -59.954 | -62.119 | -47.009 |
| Income Before Tax Ratio
| -0.398 | -0.513 | -0.662 | -0.615 | -0.387 | -0.552 | -0.643 |
| Income Tax Expense
| 0.356 | -4.28 | -6.898 | -1.194 | 0.142 | -0.135 | 0.026 |
| Net Income
| -118.147 | -137.403 | -153.21 | -115.017 | -60.096 | -61.984 | -47.035 |
| Net Income Ratio
| -0.399 | -0.497 | -0.633 | -0.609 | -0.388 | -0.551 | -0.644 |
| EPS
| -2.09 | -2.56 | -3.23 | -2.91 | -3.21 | -2.23 | -1.69 |
| EPS Diluted
| -2.09 | -2.54 | -3.23 | -2.91 | -3.21 | -2.23 | -1.69 |
| EBITDA
| -40.545 | -91.708 | -106.122 | -77.4 | -45.653 | -52.12 | -39.648 |
| EBITDA Ratio
| -0.137 | -0.332 | -0.439 | -0.41 | -0.295 | -0.463 | -0.543 |